Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Vago

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
Frontiers in Pharmacology|May 23, 2015
Improving the safety of cell therapy with the TK-suicide geneRaffaella Greco, Giacomo Oliveira, Maria Teresa Lupo Stanghellini, et al.
Frontiers in Oncology|May 17, 2024
Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case reportElisa Diral, Gloria Catalano, Maria Vittoria Cicinelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2012
Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3Hugo G Hilton, Luca Vago, Anastazia M Older Aguilar, et al.
The Journal of Experimental Medicine|November 5, 2003
Regulation of the chemokine receptor CXCR4 by hypoxiaTiziana Schioppa, Badarch Uranchimeg, Alessandra Saccani, et al.
American Journal of Hematology|March 2, 2016
Elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programsMassimo Bernardi, Matteo Carrabba, Carlo Messina, et al.
Blood|May 19, 2012
Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCTCristina Toffalori, Irene Cavattoni, Sara Deola, et al.
European Journal of Immunology|March 25, 2005
Increased inflammation in mice deficient for the chemokine decoy receptor D6Yeny Martinez de la Torre, Massimo Locati, Chiara Buracchi, et al.
Blood|November 5, 2005
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation)Subhra K Biswas, Lisa Gangi, Saki Paul, et al.
Blood|June 29, 2017
A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCTMüberra Ahci, Cristina Toffalori, Evelien Bouwmans, et al.
European Journal of Haematology|August 12, 2015
High rate of hematological responses to sorafenib in FLT3-ITD acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplantationTiago De Freitas, Sarah Marktel, Simona Piemontese, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Frontiers in Pharmacology|May 23, 2015
Improving the safety of cell therapy with the TK-suicide geneRaffaella Greco, Giacomo Oliveira, Maria Teresa Lupo Stanghellini, et al.
Frontiers in Oncology|May 17, 2024
Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case reportElisa Diral, Gloria Catalano, Maria Vittoria Cicinelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2012
Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3Hugo G Hilton, Luca Vago, Anastazia M Older Aguilar, et al.
The Journal of Experimental Medicine|November 5, 2003
Regulation of the chemokine receptor CXCR4 by hypoxiaTiziana Schioppa, Badarch Uranchimeg, Alessandra Saccani, et al.
American Journal of Hematology|March 2, 2016
Elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programsMassimo Bernardi, Matteo Carrabba, Carlo Messina, et al.
Blood|May 19, 2012
Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCTCristina Toffalori, Irene Cavattoni, Sara Deola, et al.
European Journal of Immunology|March 25, 2005
Increased inflammation in mice deficient for the chemokine decoy receptor D6Yeny Martinez de la Torre, Massimo Locati, Chiara Buracchi, et al.
Blood|November 5, 2005
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation)Subhra K Biswas, Lisa Gangi, Saki Paul, et al.
Blood|June 29, 2017
A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCTMüberra Ahci, Cristina Toffalori, Evelien Bouwmans, et al.
European Journal of Haematology|August 12, 2015
High rate of hematological responses to sorafenib in FLT3-ITD acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplantationTiago De Freitas, Sarah Marktel, Simona Piemontese, et al.
Pageof 12